普通外文研报
Beijing Health Check 284: Tightening Online Prescription Issuance by Internet Healthcare Platforms?
研报英文原文证据摘录
Beijing Health Check 284: Tightening Online Prescription Issuance by Internet Healthcare Platforms?
Update
May 14, 2026 02:56 PM GMT
Morgan Stanley Asia Limited+MBeijing Health Check 284 | Asia Pacific Alexis Yan, CFA
Equity Analyst
Tightening Online Prescription Alexis.Yan@morganstanley.comClinton Ng +852 2239-7953
Clinton.Ng@morganstanley.com +852 2848-6659
Issuance by Internet Healthcare
China Healthcare
Asia Pacific
Industry View AttractivePlatforms?
Key Takeaways
Per local news, some pharmacies received notice that hospital paper
prescriptions are required to sell certain Rx drugs (including GLP-1s), from May
15.
The New Drug Management Guidelines, also effective May 15, leave
interpretation of "high risk drugs" prohibited from online sales to the discretion of
the NMPA.
GLP-1 injectables fit into the "anti-diabetic" injectable category, for which the
existing NMPA rules allow online sales with proper prescriptions.
Also, the vast majority of online drug purchases are paid for out of pocket.
Hence, we see limited implications for the public insurance pools.
At this stage, we await more implementation details to assess the impact on
Internet healthcare platforms, if any. JDH and ALH are operating normally for
now.
Some pharmacies in Shanghai recently received notice that they will no longer be
permitted to assist patients in getting online prescriptions for certain drugs
(including GLP-1 injectables), effective May 15. It is unclear whether direct online
prescriptions on Internet healthcare platforms followed by drug purchases will also
be affected. As of May 14, JD Health and Ali Health's online prescription issuance and
sales channels remain open, per our check.
Release of New Drug Management Guidelines: The State Council also issued Doc.
本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。
打开研报阅读器